オルソバイオロジクスの世界市場レポート2025

オルソバイオロジクス市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.5％で97億米ドルに成長します。予測期間の成長は、高齢化と座りがちなライフスタイル、先進製品の継続的開発、有利な償還政策、新しい生物学的矯正製品の規制承認、既存の生物学的矯正製品の適応拡大などに起因すると考えられます。予測期間における主な動向としては、再生医療の進歩、製品の革新、技術の進歩、戦略的イニシアティブ、市場の拡大などが挙げられます。

交通事故やスポーツ傷害の発生率の上昇が、今後のオルソバイオロジクス市場の成長を牽引すると予想されます。交通事故やスポーツ傷害は、多くの場合筋骨格系に影響を及ぼす個人の身体的危害を伴う。これらの事故は、脇見運転、スピード違反、劣悪な道路環境、使い過ぎ、不適切な用具、スポーツ関連の怪我に対するトレーニング不足などの要因によって影響を受けます。オルソバイオロジクスは、骨移植片、成長因子、幹細胞、多血小板血漿などの物質を用いて、筋骨格系組織の治癒をより迅速かつ効果的に促進し、炎症を抑え、身体の自然な修復プロセスを強化することにより、これらの傷害の治療に重要な役割を果たしています。たとえば2024年3月、欧州連合（EU）の統計局であるユーロスタットは、2022年に欧州で交通事故による死者が2万653人に達し、2021年の1万9,917人に比べて3.7％増加したと報告しました。その結果、交通事故やスポーツ傷害の増加がオルソバイオロジクス市場を促進すると予想されます。

オルソバイオロジクス市場の主なプレーヤーは、整形外科手術における骨癒合と融合を改善するための先進的ソリューションを積極的に開発しています。例えば、ドライアログラフト混合物は、頑丈な皮質繊維とミネラル化した皮質骨を組み合わせ、構造的支持を提供し、新しい骨形成のための骨誘導特性を促進します。米国を拠点とする生物製剤に特化したIsto Biologics社は、2024年5月にFibrant Liberty移植片を発表しました。この移植片は、頑丈な皮質繊維とミネラル化した皮質海綿チップを一体化したものです。この移植片は、水分を含むとしなやかになり、様々な外科手術に対応できます。より長くて丈夫なファイバーは取り扱いを改善し、構造的完全性を維持しながら移植片の移動を防ぐネットワークを形成します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界オルソバイオロジクス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のオルソバイオロジクス市場：成長率分析
• 世界のオルソバイオロジクス市場の実績：規模と成長, 2019-2024
• 世界のオルソバイオロジクス市場の予測：規模と成長, 2024-2029, 2034F
• 世界オルソバイオロジクス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のオルソバイオロジクス市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 粘性サプリメント
• 骨成長因子
• 脱髄骨基質
• 合成骨代替物
• 細胞同種移植
• その他の製品
• 世界のオルソバイオロジクス市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 脊椎固定術
• 顎顔面および歯科
• 軟部組織修復
• 再建および骨折手術
• その他の用途
• 世界のオルソバイオロジクス市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 整形外科クリニック
• 外来手術センター
• その他のエンドユーザー
• 世界のオルソバイオロジクス市場粘性サプリメントの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ヒアルロン酸注射
• ゲルベースの粘性サプリメント
• 架橋ヒアルロン酸
• その他の粘性サプリメント製品
• 世界のオルソバイオロジクス市場骨成長因子の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 骨形成タンパク質（BMP）
• 組み換えヒト骨形成タンパク質（rhBMP）
• 多血小板血漿（PRP）
• 骨形成タンパク質-1（OP-1）
• 骨の治癒のための成長因子
• 世界のオルソバイオロジクス市場脱灰骨基質の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• DBM移植
• DBMパテ
• DBMスポンジ
• DBMペーストとチップ
• 世界のオルソバイオロジクス市場、タイプ別人工骨のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• リン酸カルシウム系代替品
• 硫酸カルシウムベースの代替品
• リン酸三カルシウム（TCP）
• ハイドロキシアパタイト（HA）
• バイオアクティブグラス
• その他の合成骨代替物
• 世界のオルソバイオロジクス市場細胞同種移植の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 骨細胞同種移植
• 間葉系幹細胞（MSC）同種移植
• 骨髄由来細胞同種移植
• 脂肪組織由来細胞同種移植
• 世界のオルソバイオロジクス市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自家移植
• コラーゲンベースの移植
• 合成骨移植代替物（非生体活性）
• 羊膜移植
• エクソソームベースの製品
• その他の整形生物学的製品

第7章 地域別・国別分析

• 世界のオルソバイオロジクス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のオルソバイオロジクス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• オルソバイオロジクス市場：競合情勢
• オルソバイオロジクス市場：企業プロファイル
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Zimmer Biomet Overview, Products and Services, Strategy and Financial Analysis
  • Arthrex Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Integra Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• NuVasive Inc.
• Globus Medical
• Bioventus
• MTF Biologics
• ATEC Spine Inc.
• Exactech Inc.
• SeaSpine
• RTI Surgical
• AlloSource
• XTANT MEDICAL
• Spine Wave Inc.
• Bone Biologics Corp.
• Locate Bio Limited
• Wright Medical Group N.V.
• BoneSupport AB

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• オルソバイオロジクス市場2029：新たな機会を提供する国
• オルソバイオロジクス市場2029：新たな機会を提供するセグメント
• オルソバイオロジクス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Orthobiologics refer to therapies derived from natural substances utilized in treating various musculoskeletal conditions. These therapies aim to enhance the body's capacity to repair and regenerate bones, cartilage, tendons, and ligaments in orthopedic treatments, ultimately improving recovery times and outcomes in procedures such as spinal fusion, fracture repair, and joint reconstruction.

The main products of orthobiologics include viscosupplements, bone growth factors, demineralized bone matrix, synthetic bone substitutes, cellular allografts, and others. Viscosupplements are gel-like substances injected into joints to provide lubrication and cushioning, thereby reducing pain and enhancing mobility in individuals with osteoarthritis. These products find applications across various fields, including spinal fusion, maxillofacial and dental surgeries, soft tissue repair, reconstructive and fracture surgery, and others. They are utilized by various end users such as hospitals, orthopedic clinics, ambulatory surgery centers, and others.

The orthobiologics market research report is one of a series of new reports from The Business Research Company that provides orthobiologics market statistics, including the orthobiologics industry global market size, regional shares, competitors with orthobiologics market share, detailed orthobiologics market segments, market trends, and opportunities, and any further data you may need to thrive in the orthobiologics industry. These orthobiologics market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The orthobiologics market size has grown strongly in recent years. It will grow from $7.08 billion in 2024 to $7.56 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to the rise in prevalence of orthopedic diseases and conditions, shift towards minimally invasive procedures, rise in number of reconstructive surgeries, increase in healthcare expenditure, awareness among patients and healthcare providers, and economic development in emerging markets.

The orthobiologics market size is expected to see strong growth in the next few years. It will grow to $9.7 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to the aging population and sedentary lifestyles, ongoing development of advanced products, favorable reimbursement policies, regulatory approvals for new orthobiologic products, and expanded indications for existing orthobiologic products. Major trends in the forecast period include advancements in regenerative medicine, product innovations, technological advancements, strategic initiatives, and market expansion.

The rising incidence of road accidents and sports injuries is expected to drive the growth of the orthobiologics market in the future. Road accidents and sports injuries involve physical harm to individuals, often affecting the musculoskeletal system. These incidents are influenced by factors such as distracted driving, speeding, poor road conditions, overuse, improper equipment, and insufficient training for sports-related injuries. Orthobiologics play a key role in treating these injuries by promoting faster and more effective healing of musculoskeletal tissues, reducing inflammation, and enhancing the body's natural repair processes using substances like bone grafts, growth factors, stem cells, and platelet-rich plasma. For example, in March 2024, Eurostat, the European Union's statistical office, reported that in 2022, 20,653 people were killed in road accidents in Europe, an increase of 3.7% compared to 19,917 fatalities in 2021. As a result, the growing number of road accidents and sports injuries is expected to propel the orthobiologics market.

Key players in the orthobiologics market are actively developing advanced solutions to improve bone healing and fusion in orthopedic procedures. Dry allograft mixtures, for instance, combine sturdy cortical fibers with mineralized cortical bone, offering structural support and promoting osteoinductive properties for new bone formation. Isto Biologics, a US-based biologics-focused company, introduced Fibrant Liberty allograft in May 2024, featuring robust cortical fibers integrated with mineralized cortical cancellous chips. This graft, upon hydration, becomes pliable and can be tailored for various surgical procedures. Its longer and stronger fibers improve handling and form a network that prevents graft migration while maintaining structural integrity.

In February 2023, Zimmer Biomet Holdings Inc., a US-based medical technology company, completed the acquisition of Embody Inc. for $155 million. This strategic move underscores Zimmer's commitment to investing in areas with significant growth potential and introducing innovations to benefit patients and surgeons. Embody, a US-based soft tissue healing company, specializes in developing and manufacturing collagen-based biologic products for soft tissue augmentation and repair. The acquisition includes Embody's comprehensive portfolio of collagen-based biointegrative solutions aimed at supporting healing in challenging orthopedic soft tissue injuries.

Major companies operating in the orthobiologics market are Johnson & Johnson, Medtronic plc, Zimmer Biomet, Arthrex Inc., Integra Lifesciences Corporation, NuVasive Inc., Globus Medical, Bioventus, MTF Biologics, ATEC Spine Inc., Exactech Inc., SeaSpine, RTI Surgical, AlloSource, XTANT MEDICAL, Spine Wave Inc., Bone Biologics Corp., Locate Bio Limited, Wright Medical Group N.V., BoneSupport AB, Graftys, Regenexx, Acumed LLC, Baxter International Inc., LifeNet Health

North America was the largest region in the orthobiologics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the orthobiologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the orthobiologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The orthobiologics market consists of sales of bone morphogenetic proteins, hyaluronic acid, stem cells, and platelet-rich plasma. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Orthobiologics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on orthobiologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for orthobiologics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The orthobiologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Viscosupplements; Bone Growth Factors; Demineralized Bone Matrix; Synthetic Bone Substitutes; Cellular Allograft; Other Products
• 2) By Application: Spinal Fusion; Maxillofacial And Dental; Soft Tissue Repair; Reconstructive And Fracture Surgery; Other Applications
• 3) By End User: Hospitals; Orthopedic Clinics; Ambulatory Surgery Centers; Other End Users
• Subsegments:
• 1) By Viscosupplements: Hyaluronic Acid Injections; Gel-Based Viscosupplements; Cross-linked Hyaluronic Acid; Other Viscosupplement Products
• 2) By Bone Growth Factors: Bone Morphogenetic Proteins (BMPs); Recombinant Human Bone Morphogenetic Proteins (rhBMPs); Platelet-Rich Plasma (PRP); Osteogenic Protein-1 (OP-1); Growth Factors For Bone Healing
• 3) By Demineralized Bone Matrix: DBM Grafts; DBM Putty; DBM Sponges; DBM Paste And Chips
• 4) By Synthetic Bone Substitutes: Calcium Phosphate-Based Substitutes; Calcium Sulfate-Based Substitutes; Tricalcium Phosphate (TCP); Hydroxyapatite (HA); Bioactive Glasses; Other Synthetic Bone Substitutes
• 5) By Cellular Allograft: Osteocellular Allografts; Mesenchymal Stem Cells (MSCs) Allografts; Bone Marrow-Derived Cellular Allografts; Adipose Tissue-Derived Cellular Allografts
• 6) By Other Products: Autografts; Collagen-Based Grafts; Synthetic Bone Graft Substitutes (Non-Bioactive); Amniotic Membrane-Based Grafts; Exosome-Based Products; Other Miscellaneous Orthobiologic Products
• Companies Mentioned: Johnson & Johnson; Medtronic plc; Zimmer Biomet; Arthrex Inc.; Integra Lifesciences Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Orthobiologics Market Characteristics

3. Orthobiologics Market Trends And Strategies

4. Orthobiologics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Orthobiologics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Orthobiologics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Orthobiologics Market Growth Rate Analysis
• 5.4. Global Orthobiologics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Orthobiologics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Orthobiologics Total Addressable Market (TAM)

6. Orthobiologics Market Segmentation

• 6.1. Global Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Viscosupplements
• Bone Growth Factors
• Demeneralized Bone Matrix
• Synthetic Bone Substitutes
• Cellular Allograft
• Other Products
• 6.2. Global Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Spinal Fusion
• Maxillofacial And Dental
• Soft Tissue Repair
• Reconstructive And Fracture Surgery
• Other Applications
• 6.3. Global Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Orthopedic Clinics
• Ambulatory Surgery Centers
• Other End Users
• 6.4. Global Orthobiologics Market, Sub-Segmentation Of Viscosupplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hyaluronic Acid Injections
• Gel-Based Viscosupplements
• Cross-linked Hyaluronic Acid
• Other Viscosupplement Products
• 6.5. Global Orthobiologics Market, Sub-Segmentation Of Bone Growth Factors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bone Morphogenetic Proteins (BMPs)
• Recombinant Human Bone Morphogenetic Proteins (rhBMPs)
• Platelet-Rich Plasma (PRP)
• Osteogenic Protein-1 (OP-1)
• Growth Factors For Bone Healing
• 6.6. Global Orthobiologics Market, Sub-Segmentation Of Demineralized Bone Matrix, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DBM Grafts
• DBM Putty
• DBM Sponges
• DBM Paste And Chips
• 6.7. Global Orthobiologics Market, Sub-Segmentation Of Synthetic Bone Substitutes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Calcium Phosphate-Based Substitutes
• Calcium Sulfate-Based Substitutes
• Tricalcium Phosphate (TCP)
• Hydroxyapatite (HA)
• Bioactive Glasses
• Other Synthetic Bone Substitutes
• 6.8. Global Orthobiologics Market, Sub-Segmentation Of Cellular Allograft, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Osteocellular Allografts
• Mesenchymal Stem Cells (MSCs) Allografts
• Bone Marrow-Derived Cellular Allografts
• Adipose Tissue-Derived Cellular Allografts
• 6.9. Global Orthobiologics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autografts
• Collagen-Based Grafts
• Synthetic Bone Graft Substitutes (Non-Bioactive)
• Amniotic Membrane-Based Grafts
• Exosome-Based Products
• Other Miscellaneous Orthobiologic Products

7. Orthobiologics Market Regional And Country Analysis

• 7.1. Global Orthobiologics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Orthobiologics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Orthobiologics Market

• 8.1. Asia-Pacific Orthobiologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Orthobiologics Market

• 9.1. China Orthobiologics Market Overview
• 9.2. China Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Orthobiologics Market

• 10.1. India Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Orthobiologics Market

• 11.1. Japan Orthobiologics Market Overview
• 11.2. Japan Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Orthobiologics Market

• 12.1. Australia Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Orthobiologics Market

• 13.1. Indonesia Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Orthobiologics Market

• 14.1. South Korea Orthobiologics Market Overview
• 14.2. South Korea Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Orthobiologics Market

• 15.1. Western Europe Orthobiologics Market Overview
• 15.2. Western Europe Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Orthobiologics Market

• 16.1. UK Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Orthobiologics Market

• 17.1. Germany Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Orthobiologics Market

• 18.1. France Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Orthobiologics Market

• 19.1. Italy Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Orthobiologics Market

• 20.1. Spain Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Orthobiologics Market

• 21.1. Eastern Europe Orthobiologics Market Overview
• 21.2. Eastern Europe Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Orthobiologics Market

• 22.1. Russia Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Orthobiologics Market

• 23.1. North America Orthobiologics Market Overview
• 23.2. North America Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Orthobiologics Market

• 24.1. USA Orthobiologics Market Overview
• 24.2. USA Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Orthobiologics Market

• 25.1. Canada Orthobiologics Market Overview
• 25.2. Canada Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Orthobiologics Market

• 26.1. South America Orthobiologics Market Overview
• 26.2. South America Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Orthobiologics Market

• 27.1. Brazil Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Orthobiologics Market

• 28.1. Middle East Orthobiologics Market Overview
• 28.2. Middle East Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Orthobiologics Market

• 29.1. Africa Orthobiologics Market Overview
• 29.2. Africa Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Orthobiologics Market Competitive Landscape And Company Profiles

• 30.1. Orthobiologics Market Competitive Landscape
• 30.2. Orthobiologics Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Zimmer Biomet Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Arthrex Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Integra Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Orthobiologics Market Other Major And Innovative Companies

• 31.1. NuVasive Inc.
• 31.2. Globus Medical
• 31.3. Bioventus
• 31.4. MTF Biologics
• 31.5. ATEC Spine Inc.
• 31.6. Exactech Inc.
• 31.7. SeaSpine
• 31.8. RTI Surgical
• 31.9. AlloSource
• 31.10. XTANT MEDICAL
• 31.11. Spine Wave Inc.
• 31.12. Bone Biologics Corp.
• 31.13. Locate Bio Limited
• 31.14. Wright Medical Group N.V.
• 31.15. BoneSupport AB

32. Global Orthobiologics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Orthobiologics Market

34. Recent Developments In The Orthobiologics Market

35. Orthobiologics Market High Potential Countries, Segments and Strategies

• 35.1 Orthobiologics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Orthobiologics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Orthobiologics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer